Summary:
A randomized, double-blind, multiple-site, placebo-controlled, parallel design study comparing Clindamycin 1%/ Benzoyl Peroxide 5%Topical Gel (Taro Pharmaceuticals, Inc.) to Benzaclin ® Topical Gel Clindamycin1%/ Benzoyl Peroxide 5% (Sanofi Aventis) in the treatment of Acne Vulgaris
Qualified Participants Must:
• Be between 12 and 40 years of age
•
Have moderate to severe facial acne
Qualified Participants May Receive:
One of the following:
- Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel
- Benzaclin ® Topical Gel (Clindamycin 1&/Benzoyl Peroxide 5%)
- Placebo Topical Gel (inactive medicine)